SS-loaded BSA-ApoE NPs showed higher brain uptake and superior antimigraine potential than PBCA NPs in rats, indicating the potential for improved brain targeting of sumatriptan succinate in migraine treatment. The gene discussed is APOE; the disease is migraine disorder.